MoneyWorks4Me

Amrutanjan Healthcar - Quaterly Results

04 Feb 2026 Evaluate
The Revenue for the quarter ended  December 2025 of Rs. 1410.39 millions grew by 14.90 % from Rs. 1227.52 millions.Profit for the quarter ended December 2025 grew by 1.07% to Rs. 194.51 millions from Rs. 192.45 millions.OP of the company witnessed a marginal growth to 292.87 millions from 277.09 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 1410.39 1227.52 14.90 3527.85 3164.03 11.50 4518.16 4212.30 7.26
Other Income 41.20 43.60 -5.50 128.43 128.59 -0.12 176.79 163.48 8.14
PBIDT 292.87 277.09 5.69 629.83 533.58 18.04 758.80 681.59 11.33
Interest 0.48 0.56 -14.29 1.50 1.76 -14.77 2.19 1.57 39.49
PBDT 279.87 276.53 1.21 615.81 531.82 15.79 756.61 680.02 11.26
Depreciation 16.24 16.64 -2.40 47.13 49.04 -3.89 65.26 60.57 7.74
PBT 263.63 259.89 1.44 568.68 482.78 17.79 691.35 619.45 11.61
TAX 69.12 67.44 2.49 151.47 126.22 20.00 182.99 169.73 7.81
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 194.51 192.45 1.07 417.21 356.56 17.01 508.36 449.72 13.04
Equity 28.91 28.91 0.00 28.91 28.91 0.00 28.91 28.91 0.00
PBIDTM(%) 20.77 22.57 -8.01 17.85 16.86 5.87 16.79 16.18 3.79
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..